Handbook of Thromboprophylaxis

David Perry, MD, PhD, FRCPEdin, FRCPLond, FRCPath, is Consultant in Haemostasis, Thrombosis and General Haematology at Addenbrooke's Hospital, Cambridge, UK, an Honorary Lecturer at the University of Cambridge, and Co-Director of the Haemophilia Comprehensive Care Centre. Prior to joining the staff at Addenbrooke's Hospital, he was Senior Lecturer in Hemostasis and Thrombosis at the Royal Free and University College Medical School (Royal Free Campus), London, UK. His interests include the molecular genetics of hemostasis and thrombosis, the rare inherited bleeding disorders, and the management of patients with venous thromboembolic disease, particularly in relation to pregnancy. He has published widely in the area of hemostasis and thrombosis. He is a member of the British Committee for Standards in Haematology Task Force on Haemostasis & Thrombosis, a member of the steering group for UK National External Quality Assessment Service (Blood Coagulation), and chairs the Specialist Advisory Group for Haemophilia Molecular Genetics for UK National External Quality Assessment Service. His other interests include medical education - he is examiner for the Royal College of Physicians, Edinburgh and the Royal College of Pathologists, and is the current lead physician for pathology education at Addenbrooke's Hospital. David Warwick, MD, FRCS, FRCS(Orth), is a Consultant Orthopaedic Surgeon at University Hospitals Southampton, UK. He also runs a specialized practice for patients with hand and wrist problems in Wessex and is a professorial fellow of the University of Southampton. Professor Warwick obtained his doctorate from the University of Bristol in 1995 through original research and dissertation on deep vein thrombosis and total hip replacement, and in 1998 was awarded a Hunterian Professorship at the Royal College of Surgeons, UK. His current research interests include electrical stimulation in the prevention of venous thromboembolism (VTE). Professor Warwick has won awards and prizes for his work on VTE, and has sat on several thrombosis committees, including Chairman of the International Surgical Thrombosis Forum Guidelines Committee. He is currently Section Editor for Annals of Royal College of Surgeons and serves on the Editorial Board of the Bone and Joint Journal. He has also reviewed for journals including Thrombosis and Haemostasis, Hip International, and Clinical Orthopaedics. In his research interest of VTE, he has published numerous papers in peer-reviewed journals and has written several book chapters. Professor Warwick recently authored the orthopedic section of the IUA Consensus Statement on the prevention and treatment of VTE, published in International Angiology in 2013. Professor Warwick has been invited to lecture and present at numerous international, national, and regional meetings. He also acted as an expert witness for the UK Parliamentary Select Committee on 'The Prevention of Venous Thromboembolism (VTE) in Hospitalised Patients' in December 2004, which examined barriers to effective VTE thromboprophylaxis and strategies that could be used to improve therapy in UK hospitals. He was a member of the Guideline Development group which produced the NICE guidelines for VTE prophylaxis in the UK.

Introduction.- Overview of anticoagulants.- Thromboprophylaxis in medical patients.- Introduction to thromboprophylaxis in surgical patients.- Thromboprophylaxis in orthopedic surgery.- Thromboprophylaxis in cancer surgery.- Thromboprophylaxis in other types of surgery.- Thromboprophylaxis in pregnancy.- Venous thromboprophylaxis in children.- Thromboprophylaxis in cancer patients.- Travel-related thromboprophylaxis